Ahsan Y. Khan, MD

Ahsan Y. Khan, MD is a contributing author on Psychiatrist.com. Ahsan Y. Khan has authored or co-authored 6 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2001 and 2012. Their work focuses on Depression (MDD), Metabolic Disorders, Psychiatry, Psychopharmacology, and Schizophrenia/Schizoaffective Disorders.

Depression (MDD) Metabolic Disorders Psychiatry Psychopharmacology Schizophrenia/Schizoaffective Disorders

Frequent co-authors

A. John Rush David W. Morris Madhukar H. Trivedi Maurizio Fava Moneeshindra Singh Mittal Rachna Kalia Stephen R. Wisniewski Andrew A. Nierenberg

Letter to the Editor

Dr Mittal and Colleagues Reply

December 27, 2012

Ahsan Y. Khan, Moneeshindra Singh Mittal, Rachna Kalia

Article

A Case of Psychosis After Use of a Detoxification Kit and a Review of Techniques, Risks, and Regulations Associated With the Subversion of Urine Drug Tests

October 20, 2011

In this article, the case of a 19-year-old man who developed psychosis after the use of a detoxification kit is presented. Then, a review of the existing literature on...

Ahsan Y. Khan, Moneeshindra Singh Mittal, Rachna Kalia

Letter to the Editor

Severe Weight Gain With Long-Acting Injectable Risperidone: A Case Report

August 12, 2010

Weight gain is a major problem with second-generation antipsychotics. Here, delve into the case of a patient diagnosed with schizophrenia, catatonic type, who gained 84 lb during 14 months...

Ahsan Y. Khan, Matthew Macaluso

Original Research

Response to a Selective Serotonin Reuptake Inhibitor (Citalopram) in Major Depressive Disorder With Melancholic Features: A STAR*D Report

December 31, 2008

Maurizio Fava, Andrew A. Nierenberg, Madhukar H. Trivedi, et al

Original Research

Diurnal Mood Variation in Outpatients With Major Depressive Disorder: Implications for DSM-V From an Analysis of the Sequenced Treatment Alternatives to Relieve Depression Study Data

September 17, 2007

Maurizio Fava, Madhukar H. Trivedi, Stephen R. Wisniewski, et al

Letter to the Editor

Increase in Plasma Levels of Clozapine and Norclozapine After Administration of Nefazodone

May 1, 2001

Ahsan Y. Khan, Sheldon H. Preskorn

Ahsan Y. Khan, MD

Frequent co-authors

Dr Mittal and Colleagues Reply

A Case of Psychosis After Use of a Detoxification Kit and a Review of Techniques, Risks, and Regulations Associated With the Subversion of Urine Drug Tests

Severe Weight Gain With Long-Acting Injectable Risperidone: A Case Report

Response to a Selective Serotonin Reuptake Inhibitor (Citalopram) in Major Depressive Disorder With Melancholic Features: A STAR*D Report

Diurnal Mood Variation in Outpatients With Major Depressive Disorder: Implications for DSM-V From an Analysis of the Sequenced Treatment Alternatives to Relieve Depression Study Data

Increase in Plasma Levels of Clozapine and Norclozapine After Administration of Nefazodone

ELSEWHERE:

FOLLOW US:

Ahsan Y. Khan, MD

Frequent co-authors

Dr Mittal and Colleagues Reply

A Case of Psychosis After Use of a Detoxification Kit and a Review of Techniques, Risks, and Regulations Associated With the Subversion of Urine Drug Tests

Severe Weight Gain With Long-Acting Injectable Risperidone: A Case Report

Response to a Selective Serotonin Reuptake Inhibitor (Citalopram) in Major Depressive Disorder With Melancholic Features: A STAR*D Report

Diurnal Mood Variation in Outpatients With Major Depressive Disorder: Implications for DSM-V From an Analysis of the Sequenced Treatment Alternatives to Relieve Depression Study Data

Increase in Plasma Levels of Clozapine and Norclozapine After Administration of Nefazodone

Live Webinar and Q&A With Dr Deligiannidis

Subscribe to readmore articles

Live Webinar
and Q&A With
Dr Deligiannidis

Subscribe to read
more articles